Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This is a multi-center, double-blind, randomized, Phase 2b trial to evaluate the efficacy of atacicept in subjects with systemic lupus erythematosus (SLE).
Epistemonikos ID: 58d9467280fbbf95334d9bb2c886015c07f993ab
First added on: May 11, 2024